Avalere Analysis: 90% of Companies Offer Cost-Sharing Assistance to Exchange Enrollees, But Program Characteristics Vary Widely

  • This page as PDF

Summary

A recently-completed Avalere Health survey finds that while 90 percent of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Additionally, while most companies are beginning to transition patients off of patient assistance programs (PAPs), companies are doing so incrementally given ongoing uncertainty in the market. Avalere’s comprehensive report is now available for purchase, which provides in-depth quantitative findings and a glimpse into this rapidly evolving market.

For details, please contact your Avalere account lead or Lauren Barnes (lbarnes@avalere.com).

Webinar | Valuing the Patient Perspective: Patient-Centered HTA

On April 25 at 1 PM, this expert panel will address the challenge of integrating patient perspectives into value assessments, discussing implications for evidence strategy, health equity, caregiver involvement, and downstream impacts on care delivery. Learn More
Register Now

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top